Fluorine in PDB 8e1a: Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors

Protein crystallography data

The structure of Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors, PDB code: 8e1a was solved by N.Lallous, H.Li, M.Radaeva, K.Dalal, E.Leblanc, F.Ban, F.Ciesielski, B.Chow, M.Morin, K.Singh, P.S.Rennie, A.Cherkasov, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 40.00 / 1.20
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 54.953, 65.762, 69.128, 90, 90, 90
R / Rfree (%) 12.4 / 15.1

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors (pdb code 8e1a). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors, PDB code: 8e1a:

Fluorine binding site 1 out of 1 in 8e1a

Go back to Fluorine Binding Sites List in 8e1a
Fluorine binding site 1 out of 1 in the Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1001

b:12.2
occ:1.00
FAA A:3E01001 0.0 12.2 1.0
CAB A:3E01001 1.4 11.8 1.0
CAC A:3E01001 2.3 12.1 1.0
CAF A:3E01001 2.4 11.7 1.0
CAE A:3E01001 2.7 14.5 1.0
OAD A:3E01001 2.7 12.2 1.0
O A:HOH1224 3.3 13.4 1.0
CB A:MET749 3.3 9.0 1.0
NH2 A:ARG752 3.4 9.9 1.0
CG A:MET749 3.4 9.2 1.0
CD1 A:PHE764 3.4 8.6 1.0
CAI A:3E01001 3.6 11.6 1.0
CAG A:3E01001 3.6 11.2 1.0
O A:MET745 3.8 7.8 1.0
CAH A:3E01001 4.1 11.4 1.0
CE1 A:PHE764 4.1 9.2 1.0
CA A:PHE764 4.3 8.4 1.0
O A:PHE764 4.3 8.4 1.0
CG A:PHE764 4.3 7.6 1.0
CB A:MET745 4.3 7.9 1.0
C A:MET745 4.4 7.5 1.0
CB A:PHE764 4.4 8.5 1.0
CA A:MET749 4.6 7.6 1.0
CZ A:ARG752 4.7 9.0 1.0
C A:PHE764 4.8 7.3 1.0
CA A:MET745 4.8 7.9 1.0
CE A:MET749 4.8 13.1 1.0
CAJ A:3E01001 4.9 11.0 1.0
CD2 A:LEU707 4.9 9.3 1.0
SD A:MET749 4.9 9.8 1.0
N A:MET749 5.0 8.2 1.0

Reference:

M.Radaeva, H.Li, E.Leblanc, K.Dalal, F.Ban, F.Ciesielski, B.Chow, H.Morin, S.Awrey, K.Singh, P.S.Rennie, N.Lallous, A.Cherkasov. Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors. Cells V. 11 2022.
ISSN: ESSN 2073-4409
PubMed: 36139361
DOI: 10.3390/CELLS11182785
Page generated: Fri Aug 2 17:41:47 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy